63-39-8
63-39-8 結(jié)構(gòu)式
基本信息
URIDINE 5'-TRIPHOSPHATE
URIDINE-5'-TRIPHOSPHATE NA3-SALT
URIDINE-5'-TRIPHOSPHATE SODIUM
URIDINE 5'-TRIPHOSPHATE SODIUM SALT
URIDINE 5-TRIPHOSPHATE TRISODIUM
URIDINE-5'-TRIPHOSPHATE TRISODIUM SALT
URIDINE-5'-TRIPHOSPHORIC ACID, TRISODIUM
UTP
UTP, 3NA
UTP-NA
UTP, NA3H
UTP SODIUM SALT
UTP TRISODIUM SALT
5’-utp
uridine,5’-(tetrahydrogentriphosphate)
uridine5’-triphosphoricacid
uridinetriphosphate
uteplex
Uracylic
物理化學(xué)性質(zhì)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2025/02/08 | HY-107372 | 尿苷5'-三磷酸酯 Uridine triphosphate | 63-39-8 | 5 mg | 375元 |
| 2025/02/08 | HY-107372 | 尿苷5'-三磷酸酯 Uridine triphosphate | 63-39-8 | 10mg | 600元 |
| 2025/02/08 | HY-107372 | 尿苷5'-三磷酸酯 Uridine triphosphate | 63-39-8 | 50mg | 1200元 |
常見問題列表
|
Human Endogenous Metabolite
|
Uridine triphosphate treatment induces Schwannoma cell migration through activation of P2Y2 receptors and through the increase of extracellular matrix metalloproteinase-2 (MMP-2) activation and expression. Uridine triphosphate-induced proliferation is mediated by protein kinase D, Src-family tyrosine kinase, Ca/calmodulin-dependent protein kinase II, phosphatidylinositol 3-kinase (PI3K), Akt, and phospholipase D. Uridine triphosphate increases phosphorylation of Akt through protein kinase C, Src-family tyrosine kinase, Ca/calmodulin-dependent protein kinase II, and PI3K.
Uridine triphosphate reduces mitochondrial calcium levels following hypoxia. Early or late uridine triphosphate preconditioning is effective to reduce infarct size and superior myocardial function. Uridine triphosphate treatment increases the number of monocytes and macrophages infiltrating the pouch and up-regulates the gene expression of IL-4 and IL-13 in the regional lymph nodes.